Read + Share
Amedeo Smart
Independent Medical Education
Marx N, Husain M, Lehrke M, Verma S, et al. GLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes. Circulation 2022;146:1882-1894.PMID: 36508493
Email
LinkedIn
Facebook
Twitter
Privacy Policy